imatinib mesylate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
67184-0532 -
Package NDC
67184-0532-1 -
Package NDC
67184-0532-2 -
Package NDC
67184-0532-3 -
Application number
ANDA212135 -
SPL ID
a41dbedd-ee4e-401c-b446-a435929ff903 -
SPL set ID
82eb01e0-8685-4f06-8a72-7663e8ded38f -
UNII
8A1O1M485B -
RxCUI
403878 -
RxCUI
403879
What the source publishes
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Active ingredients
- imatinib mesylate
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "imatinib mesylate",
"splId": "a41dbedd-ee4e-401c-b446-a435929ff903",
"labels": [
{
"setId": "82eb01e0-8685-4f06-8a72-7663e8ded38f",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=82eb01e0-8685-4f06-8a72-7663e8ded38f",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=82eb01e0-8685-4f06-8a72-7663e8ded38f"
}
],
"routes": [
"ORAL"
],
"labeler": "Qilu Pharmaceutical Co., Ltd.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (67184-0532-1)",
"package_ndc": "67184-0532-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20220621"
},
{
"sample": false,
"description": "500 TABLET in 1 BOTTLE (67184-0532-2)",
"package_ndc": "67184-0532-2",
"identifierStatus": "well-formed",
"marketing_start_date": "20220621"
},
{
"sample": false,
"description": "30 BLISTER PACK in 1 CARTON (67184-0532-3) / 10 TABLET in 1 BLISTER PACK",
"package_ndc": "67184-0532-3",
"identifierStatus": "well-formed",
"marketing_start_date": "20220621"
}
],
"productId": "67184-0532_a41dbedd-ee4e-401c-b446-a435929ff903",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "67184-0532",
"deaSchedule": null,
"genericName": "imatinib mesylate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "IMATINIB MESYLATE",
"strength": "100 mg/1"
}
],
"applicationNumber": "ANDA212135",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220621",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0367184053322",
"0367184053223"
],
"unii": [
"8A1O1M485B"
],
"rxcui": [
"403878",
"403879"
],
"spl_set_id": [
"82eb01e0-8685-4f06-8a72-7663e8ded38f"
],
"manufacturer_name": [
"Qilu Pharmaceutical Co., Ltd."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:67184-0532_a41dbedd-ee4e-401c-b446-a435929ff903"